Clinical Trial Update: LY3214996 in Patients With AML Who Are Not Candidates for Standard Therapy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for LY3214996 in patients with acute myeloid leukemia who are not candidates for standard therapy, with the study status shown a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• LY3214996

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED